X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with MUNDRA PORT & SEZ - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs ADANI PORTS & SEZ - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES ADANI PORTS & SEZ INDOCO REMEDIES/
ADANI PORTS & SEZ
 
P/E (TTM) x 22.6 20.0 113.0% View Chart
P/BV x 2.7 4.5 59.8% View Chart
Dividend Yield % 0.8 0.3 246.5%  

Financials

 INDOCO REMEDIES   ADANI PORTS & SEZ
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
ADANI PORTS & SEZ
Mar-17
INDOCO REMEDIES/
ADANI PORTS & SEZ
5-Yr Chart
Click to enlarge
High Rs360342 105.4%   
Low Rs249170 146.4%   
Sales per share (Unadj.) Rs119.040.8 292.1%  
Earnings per share (Unadj.) Rs8.418.8 44.4%  
Cash flow per share (Unadj.) Rs15.224.4 62.3%  
Dividends per share (Unadj.) Rs1.601.30 123.1%  
Dividend yield (eoy) %0.50.5 103.4%  
Book value per share (Unadj.) Rs70.784.6 83.5%  
Shares outstanding (eoy) m92.152,070.95 4.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.66.3 40.7%   
Avg P/E ratio x36.413.6 268.0%  
P/CF ratio (eoy) x20.010.5 191.0%  
Price / Book Value ratio x4.33.0 142.4%  
Dividend payout %19.16.9 277.2%   
Avg Mkt Cap Rs m28,083530,370 5.3%   
No. of employees `0006.01.4 446.1%   
Total wages/salary Rs m2,1673,831 56.6%   
Avg. sales/employee Rs Th1,817.062,375.1 2.9%   
Avg. wages/employee Rs Th359.02,831.8 12.7%   
Avg. net profit/employee Rs Th127.728,835.9 0.4%   
INCOME DATA
Net Sales Rs m10,96884,394 13.0%  
Other income Rs m4010,401 0.4%   
Total revenues Rs m11,00794,795 11.6%   
Gross profit Rs m1,56556,921 2.7%  
Depreciation Rs m63311,602 5.5%   
Interest Rs m6213,932 0.4%   
Profit before tax Rs m90941,789 2.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m093 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1392,866 4.8%   
Profit after tax Rs m77139,015 2.0%  
Gross profit margin %14.367.4 21.2%  
Effective tax rate %15.36.9 222.4%   
Net profit margin %7.046.2 15.2%  
BALANCE SHEET DATA
Current assets Rs m5,725119,074 4.8%   
Current liabilities Rs m5,45465,559 8.3%   
Net working cap to sales %2.563.4 3.9%  
Current ratio x1.01.8 57.8%  
Inventory Days Days6228 218.9%  
Debtors Days Days7285 84.5%  
Net fixed assets Rs m5,307255,675 2.1%   
Share capital Rs m1844,142 4.4%   
"Free" reserves Rs m6,331171,118 3.7%   
Net worth Rs m6,516175,260 3.7%   
Long term debt Rs m1,323179,932 0.7%   
Total assets Rs m11,970435,851 2.7%  
Interest coverage x15.64.0 391.2%   
Debt to equity ratio x0.21.0 19.8%  
Sales to assets ratio x0.90.2 473.2%   
Return on assets %7.012.1 57.3%  
Return on equity %11.822.3 53.1%  
Return on capital %12.415.7 78.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,5070-   
Fx outflow Rs m1,1413,789 30.1%   
Net fx Rs m3,366-3,789 -88.8%   
CASH FLOW
From Operations Rs m88640,019 2.2%  
From Investments Rs m-1,706-25,794 6.6%  
From Financial Activity Rs m1,316-13,247 -9.9%  
Net Cashflow Rs m4971,080 46.0%  

Share Holding

Indian Promoters % 59.2 49.8 118.9%  
Foreign collaborators % 0.0 6.4 -  
Indian inst/Mut Fund % 12.5 14.4 86.8%  
FIIs % 6.0 23.9 25.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 5.5 407.3%  
Shareholders   12,805 308,354 4.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   TALWALKARS BETTER VAL.  TIMKEN INDIA  NALWA SONS INV  BAJAJ FINANCE  JSW HOLDINGS  



Today's Market

Flat Finish to the Week; Cadila Healthcare Rallies 7%(Closing)

Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks, software stocks and capital good stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS